All Episodes
|
170
|
Dr. Robert Hariri

Podcast 170: Advancing Medicine With Placenta-Derived Cells with Dr. Robert Hariri

Aug 20, 2024

Episode Summary

Join us as we delve into the groundbreaking world of cellular therapies with Dr. Robert Hariri, CEO of Celularity. In this episode, Dr. Hariri takes us on a journey through the cutting-edge innovations that are reshaping the future of medicine. Discover how harnessing the power of the body’s own cells is not just a promise for the future, but a reality today—transforming hope into tangible results across a wide spectrum of diseases. Don’t miss this insightful conversation on the therapies that are revolutionizing healthcare.

Episode Notes

Join us as we delve into the groundbreaking world of cellular therapies with Dr. Robert Hariri, CEO of Celularity.

In this episode, Dr. Hariri takes us on a journey through the cutting-edge innovations that are reshaping the future of medicine.

Discover how harnessing the power of the body’s own cells is not just a promise for the future, but a reality today—transforming hope into tangible results across a wide spectrum of diseases. Don’t miss this insightful conversation on the therapies that are revolutionizing healthcare.

🎙ABOUT DR. ROBERT HARIRI:

Dr. Bob Hariri is a pioneering surgeon, biomedical scientist, and serial entrepreneur with expertise in biomedicine and aerospace. He is the founder, chairperson, and CEO of Celularity, Inc., a leader in human cellular therapeutics, and previously founded Anthrogenesis Corporation, which was acquired by Celgene, where he served as CEO of Celgene Cellular Therapeutics.

He also co-founded Human Longevity, Inc. Dr. Hariri is renowned for pioneering the use of stem cells in treating life-threatening diseases, including the discovery of pluripotent stem cells from the human placenta. His innovations have led to over 170 patents and numerous accolades, including the Pontifical Medal for Innovation and the Thomas Alva Edison Award.

He is an Adjunct Professor of Neurosurgery at Weill Cornell Medical College and serves on various prestigious boards, including the Liberty Science Center and the X PRIZE Foundation. Beyond his medical and scientific contributions, Dr. Hariri is an accomplished jet-rated pilot and film producer.

🎙 ABOUT JOHN MARCHICA, HOST OF HEALTH CARE ROUNDS:

John Marchica is a veteran health care strategist and CEO of Darwin Research Group, a strategic consulting and market intelligence firm focused on hospitals, health systems, physician groups, and the evolving health care ecosystem. John has a degree in economics from Knox College, an MBA and M.A. in public policy from the University of Chicago, and completed his Ph.D. coursework at The Dartmouth Institute. He is an active member of the American College of Healthcare Executives and is pursuing certification as a Fellow.

CONNECT WITH US:

🌐 Visit us on the web

🌐 Follow Health Care Rounds on LinkedIn

🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media

Recommended Next

Podcast 200: How Health Systems Build Elite Clinical Leaders w/ Dr. Jonathan Stallkamp, CMO, Main Line Health
Podcast 199: A New Blueprint for Rural Health Care w/ Natalie L. Baggio, President, Corewell Health South
Podcast 198: Standing Strong as an Independent Health System w/ Dr. Allen Smith & Dr. Sam Ash, South Shore Health
Podcast 197: Making Health Care Costs Simple and Transparent w/ Mark Cuban, Co-Founder, Cost Plus Drugs
Podcast 196: Physician Leadership in a New Era of Health Care w/ Dr. Sowmya Viswanathan, Baycare
Podcast 195: Why Primary Care Is Under Strain w/ Dr. Greg Whisman, Chief Medical Officer, CareMore Health
Podcast 194: Why Health Care Reform Keeps Failing w/ Dr. David Shulkin
Podcast 193: The New Model for Specialty Pharmacy w/ Jigar Thakkar, PharmD

Recommended Content

Browse Library
INsights
February 16, 2026

Darwin's Our Take: Feature: A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes

Read More
INsights
February 9, 2026

Darwin's Our Take: Lilly’s, Novo Nordisk’s share prices roller-coaster following earnings reports

Read More
INsights
February 2, 2026

Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations

Read More
Stay Aware. Stay Informed.

Subscribe to Our Take

Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.